Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2021-10-21 M&A Activity
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the completion of an acquisition by Nurosene Health of NetraMark. It details the terms of the acquisition, including purchase price, shares issued, and cash paid, as well as background information on both companies. There is no financial statement, quarterly or annual report data, or detailed financial analysis. The document is an announcement of a corporate transaction (acquisition) rather than a merger proxy statement or tender offer filing. It fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is moderate and contains substantive information about the acquisition, not just a brief notice or report publication announcement. Therefore, the classification is TAR with high confidence.
2021-10-21 English
News release - English.pdf
Regulatory Filings
2021-10-18 English
News release - English.pdf
Regulatory Filings
2021-10-12 English
News release - English.pdf
Regulatory Filings
2021-10-04 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the addition of NHL star James van Riemsdyk to Nurosene's Mental Health Advisory Council. It focuses on a personnel appointment related to advisory roles and does not contain financial data, regulatory filings, or report announcements. There is no indication of financial results, board changes, or shareholder votes. The content is primarily a corporate announcement about management/advisory personnel changes, which fits best under Board/Management Information (MANG). The document length is about 5,266 characters, which is consistent with a typical announcement rather than a full report or transcript.
2021-09-30 English
News release - English.pdf
Investor Presentation Classification · 95% confidence The document is a press release announcing that Nurosene Health Inc. will present at the Benzinga Healthcare Small Cap Conference. It includes details about the presentation date, time, and speaker, as well as contact information for investor meetings. There is no financial data, no detailed report, no voting results, no regulatory filing, and no mention of any report being attached or published. The content is primarily an investor presentation announcement. Given the nature of the document as a presentation announcement and the absence of actual financial statements or detailed report content, the most appropriate classification is Investor Presentation (IP). The document length is short and focused on the presentation event, not a full report or regulatory filing.
2021-09-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.